Non-hdl-c levels
Pro Research Analysisby 
Searched over 200M research papers for "non-hdl-c levels"
Consensus Meter
Non-HDL-C Levels: A Comprehensive Overview
Non-HDL-C vs. LDL-C in Cardiovascular Risk Assessment
Relevance to Atherogenic Lipoprotein Subfractions
Non-high-density lipoprotein cholesterol (non-HDL-C) has been shown to be more relevant to atherogenic lipoprotein subfractions compared to low-density lipoprotein cholesterol (LDL-C) in patients with stable coronary artery disease (CAD). Studies indicate that non-HDL-C is more strongly associated with small LDL particles and mean LDL particle size, which are critical markers of atherogenicity. This suggests that non-HDL-C may be a better marker for assessing cardiovascular risk in these patients.
Superior Predictor of Small-Dense LDL Cholesterol
In Japanese subjects with triglyceride (TG) levels below 400 mg/dL, non-HDL-C has been found to be a superior predictor of small-dense LDL cholesterol (sdLDL-C) compared to LDL-C. The correlation coefficient for non-HDL-C with sdLDL-C was significantly higher, indicating a stronger predictive value. This reinforces the utility of non-HDL-C in identifying individuals at higher risk of cardiovascular events due to elevated sdLDL-C levels.
Non-HDL-C Across Different Life Stages
Association with Coronary Artery Calcification
Elevated non-HDL-C levels at various life stages, including adolescence, young adulthood, and mid-adulthood, have been associated with the presence of coronary artery calcification (CAC) in mid-adulthood. Notably, non-HDL-C levels during adolescence showed the strongest association with CAC, highlighting the importance of monitoring non-HDL-C from an early age to mitigate long-term cardiovascular risks.
Predictive Value for Cardiovascular Disease Mortality
Long-term studies have demonstrated that non-HDL-C is a more potent predictor of cardiovascular disease (CVD) mortality than LDL-C. In a 22-year follow-up study, non-HDL-C levels were significantly associated with increased risk of CVD mortality, even after adjusting for potential confounders. This suggests that non-HDL-C may be a more reliable marker for long-term cardiovascular risk assessment .
Non-HDL-C in Special Populations
Hemodialysis Patients
Interestingly, in patients undergoing hemodialysis, higher non-HDL-C levels were paradoxically associated with better outcomes, including lower all-cause and cardiovascular mortality. This inverse relationship contrasts with the general population and suggests that the role of non-HDL-C in this specific group may differ, potentially due to the unique metabolic conditions associated with hemodialysis.
Children and Adolescents
Non-HDL-C levels in children and adolescents vary by age, sex, race/ethnicity, and weight status. The prevalence of high non-HDL-C levels is significant in certain demographic groups, indicating the need for tailored screening and intervention strategies in youth to address early cardiovascular risk factors.
Conclusion
Non-HDL-C has emerged as a critical marker for cardiovascular risk assessment, often outperforming LDL-C in various contexts. Its strong association with atherogenic lipoprotein subfractions, superior predictive value for sdLDL-C, and significant correlation with long-term cardiovascular outcomes underscore its importance. Monitoring non-HDL-C levels across different life stages and in special populations can provide valuable insights for early intervention and improved cardiovascular health outcomes.
Sources and full results
Most relevant research papers on this topic